e-Pharma Market Recent Trends, Development, Growth and Forecast 2021-2028

Posted by sandra k on February 23rd, 2023

The e-pharma market is projected to grow at a CAGR of 18.90%, with an estimated market size of USD 50.5 billion in 2021 to USD 142.7 billion by 2028. Rising government initiatives, changing regulations, rising prevalence of e-prescriptions, increasing internet penetration in urban and rural areas, and rising use of emerging technologies like artificial intelligence (A.I.) and machine learning (ML) are all major factors accelerating the market growth. These technologies also help ensure customer satisfaction by way of recommendation engines. Additionally, the pharmaceutical industry's growing usage of e-commerce platforms is now driving market expansion. The expansion of the global market is also being aided by an expanding range of in-app features, such as exclusive discounts, personalized purchases, faster delivery, etc. The market is also growing due to improved internet access and the extensive usage of smart devices.

Read Comprehensive Overview of Report @ https://marketsnresearch.com/report/1566/e-pharma-market

Rise in the geriatric population

The rise of the global e-pharma market is driven by the rising prevalence rates of lifestyle illnesses, including diabetes and obesity, rising healthcare spending, and the quickly expanding diagnostic industry. The e-pharma business is also driven by the aging population, rising demand for laboratory automation, and increased awareness of preventative healthcare. Additionally, growing R&D in the healthcare industry, growing geriatric population bases in emerging regions, and growing technical improvements and modernization in the healthcare industry will all lead to new opportunities for the e-pharma market.

Key Market Players

The e-pharma market is dominated by a few global players and comprises several regional players. Some key manufacturers operating in the market are Boehringer Ingelheim International GmbH (Germany), AbbVie Inc (U.S.), Aurobindo Pharma (India), Pfizer Inc. (U.S.), Walmart Inc. (U.S.), Walgreen Co. (U.S.), Express Scripts (U.S.), The Kroger Co. (U.S.), L Rowland & Co (U.K.), DocMorris (Germany), Giant Eagle, Inc. (U.S.), OptumRx, Inc. (U.S.), CVS Health (U.S.), Merck & Co., Inc. (U.S.) and Thermo Fisher Scientific Inc. (U.S.).

Read More News : 

https://www.linkedin.com/pulse/global-e-pharma-market-garner-1427-billion-2028-1890-cagr-vasa/?published=t

https://www.internationalnewsledger.com/article/599329457-e-pharma-market-set-to-reach-usd-142-7-billion-by-2028-share-industry-size-future-growth-trends-analysis-report-with-covid-19-impact-by-markets-n